BioMarin Pharmaceuticals Inc (BMRN) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for BMRN. 13F holdings as of 2026-09-30.
In 13F filings for the quarter ended September 30, 2026, 432 institutions reported holding BMRN, with 136.8 million shares worth $8.2 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 20,735,548 | $1.2B | INCREASED |
| Vanguard | 18,658,617 | $1.1B | DECREASED |
| Primecap Management Co | 14,988,996 | $899M | INCREASED |
| Dodge & Cox | 14,625,740 | $878M | DECREASED |
| State Street | 8,339,782 | $500M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Gregory R Friberg (EVP, Chief R&D Officer) | TAX-W | 4,086 | $245K | 2026-09-30 |
Full institutional holdings, insider history, and congressional trades for BioMarin Pharmaceuticals Inc on SentiSense.